Inovio Pharmaceuticals's top three insider shareholders as of May 04, 2026 are Jong Joseph Kim (Chief Executive Officer, 1.42Mn shares), David B. Weiner (Director, 87.59K shares), Jacqueline Elizabeth Shea (Chief Executive Officer, 85.00K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Jong Joseph Kim | Chief Executive Officer | 1,422,627 | 0 | 14 Mar, 2022 |
| David B. Weiner | - | 87,592 | 0 | 27 Feb, 2026 |
| Jacqueline Elizabeth Shea | Chief Executive Officer | 85,004 | 0 | 27 Feb, 2026 |
| Laurent Humeau | Chief Scientific Officer | 39,900 | 0 | 27 Feb, 2026 |
| Peter Kies | Cfo | 36,642 | 0 | 27 Feb, 2026 |
| Michael John Sumner | Chief Medical Officer | 33,576 | 0 | 01 Apr, 2026 |
| Simon X Benito | - | 12,191 | 0 | 21 May, 2025 |
| Wendy L Yarno | - | 10,512 | 0 | 21 May, 2025 |
| Jay Shepard | - | 9,209 | 0 | 21 May, 2025 |
| Roger D Dansey | - | 8,916 | 0 | 21 May, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 31 Mar, 2026 | Michael John Sumner | Common Stock | A | 4,292 | - | 34,799 | D | M |
| 31 Mar, 2026 | Michael John Sumner | Common Stock | D | 1,223 | $1.74 | 33,576 | D | F |
| 31 Mar, 2026 | Michael John Sumner | Restricted Stock Unit | D | 4,292 | $0.00 | 0 | D | M |
| 04 Mar, 2026 | Laurent Humeau | Common Stock Option | A | 26,840 | $0.00 | 26,840 | D | A |
| 04 Mar, 2026 | Michael John Sumner | Common Stock Option | A | 36,832 | $0.00 | 36,832 | D | A |
| 04 Mar, 2026 | Jacqueline Elizabeth Shea | Common Stock Option | A | 97,240 | $0.00 | 97,240 | D | A |
| 04 Mar, 2026 | Peter Kies | Common Stock Option | A | 31,240 | $0.00 | 31,240 | D | A |
| 04 Mar, 2026 | Jacqueline Elizabeth Shea | Restricted Stock Unit | A | 78,760 | $0.00 | 78,760 | D | A |
| 04 Mar, 2026 | Peter Kies | Restricted Stock Unit | A | 25,520 | $0.00 | 25,520 | D | A |
| 04 Mar, 2026 | Michael John Sumner | Restricted Stock Unit | A | 29,608 | $0.00 | 29,608 | D | A |
| 04 Mar, 2026 | Laurent Humeau | Restricted Stock Unit | A | 21,560 | $0.00 | 21,560 | D | A |
| 26 Feb, 2026 | Peter Kies | Common Stock | A | 5,010 | - | 35,267 | D | M |
| 26 Feb, 2026 | Laurent Humeau | Common Stock | A | 5,010 | - | 37,632 | D | M |
| 26 Feb, 2026 | David B. Weiner | Common Stock | A | 972 | - | 87,592 | D | M |
| 26 Feb, 2026 | Jacqueline Elizabeth Shea | Common Stock | A | 18,632 | - | 78,317 | D | M |
| 26 Feb, 2026 | Michael John Sumner | Common Stock | A | 5,010 | - | 22,860 | D | M |
| 26 Feb, 2026 | Peter Kies | Common Stock | D | 2,965 | $1.79 | 32,302 | D | F |
| 26 Feb, 2026 | Jacqueline Elizabeth Shea | Common Stock | D | 8,057 | $1.79 | 70,260 | D | F |
| 26 Feb, 2026 | Michael John Sumner | Common Stock | A | 11,550 | - | 34,410 | D | M |
| 26 Feb, 2026 | David B. Weiner | Restricted Stock Unit | D | 972 | $0.00 | 0 | D | M |